arBtrage CAPITALIZING MARKETS checking… Sign in Sign up

Celldex Therapeutics, Inc.

CLDX Health Care Biotechnology: In Vitro & In Vivo Diagnostic Substances
$28.62
▼ -4.4% Today
as of Jun 7, 07:11 ET
Last 30 days -13.87% Apr 28 → Jun 05
$28.16 $29.83 $31.51 $33.18 $34.85 Apr 28 May 05 May 13 May 20 May 29 Jun 05
Open
$29.83
High
$30.05
Low
$28.46
Volume
$1M
Avg Vol
$992,021
Mkt Cap
$2.5B
P/E (TTM)
Beta
52w High
$35.79
52w Low
$19.25
Div Yield
Shares Out
$67M

Overview

52-week range
$19
$36
57% of range
Avg surprise (last 2)
-7.6%
Avg reaction (last 2)
+0.1%
50% positive
Latest IV / EM
112%
EM ±15.5% · $29 · Jun 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-1.18$-1.02$-0.86$-0.70$-0.54 Actual $-0.65Actual $-0.81Actual $-0.56Actual $-0.54Actual $-0.64Actual $-0.81Est $-0.75Actual $-0.85Actual $-1.01Actual $-1.18Est $-1.10 JunSepMarJunSepMar/2025JunSepMar/2026
Revenue vs Net Income Revenue Net income
$-79M$-68M$-58M$-48M$-38M Jun 24Sep 24Mar 25Jun 25Sep 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Thu May 7, 2026Mar/2026 $-1.18 $-1.10 -7.3% -45.7% -3.1% earnings
Tue Sep 30, 2025Sep 2025 $-1.01 financials
Mon Jun 30, 2025Jun 2025 $-0.85 financials
Thu May 8, 2025Mar/2025 $-0.81 $-0.75 -8.0% +3.2% earnings
Mon Sep 30, 2024Sep 2024 $-0.64 financials
Sun Jun 30, 2024Jun 2024 $-0.54 financials
Sun Mar 31, 2024Mar 2024 $-0.56 financials
Sat Sep 30, 2023Sep 2023 $-0.81 financials
Fri Jun 30, 2023Jun 2023 $-0.65 financials

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue
Cost of revenue
Gross profit
Operating income$-84M$-74M$-64M$-63M$-52M$-46M
Net income$-79M$-67M$-57M$-54M$-42M$-36M
EPS (diluted)$-1.18$-1.01$-0.85$-0.81$-0.64$-0.54

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$36M$29M$36M$23M$17M$28M$36M$43M
Inventory
Total current assets$459M$535M$604M$648M$694M$747M$779M$812M
Total assets$511M$583M$648M$692M$739M$792M$823M$846M
Long-term debt
Total liabilities$55M$56M$50M$37M$36M$45M$37M$32M
Total equity$456M$527M$598M$655M$703M$747M$786M$814M

Implied volatility — last 90 days

107%109%112%114%117% Jun 07 — IV 112% · EM ±15.5%

Sector peers

🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.